申请人:ZENECA LIMITED
公开号:EP0532177A1
公开(公告)日:1993-03-17
Compounds of formula I, and pharmaceutically acceptable salts thereof, useful in the treatment of neuropsychisatric disoders such as psychoses; pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable diluent or carrier ; and methods of treating neuropschiatric disorders comprising administering to a mammal (including man) in need of such treatment an effective amount of a compound of formula I, or a pharmaceutically acceptable salts thereof.
用于治疗神经精神疾病(如精神病)的式 I 化合物及其药学上可接受的盐;包含式 I 化合物和药学上可接受的稀释剂或载体的药物组合物;以及治疗神经精神疾病的方法,包括向需要治疗的哺乳动物(包括人)施用有效量的式 I 化合物或其药学上可接受的盐。